[1]
Yellanki, S.K. 2015. DESIGN AND IN VITRO EVALUATION OF ORALLY DISINTEGRATINGTABLETS OF SELEGILINE. International Journal of Current Pharmaceutical Research. 7, 2 (Apr. 2015), 37–39.